HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript March 12, 2026 HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15728 EPS, expectations were $-0.1375. Operator: ...
Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal ...
Q4 2025 Earnings Call March 11, 2026 3:00 PM EDTCompany ParticipantsDavid Ritchie - General Counsel & Corporate ...
HM Exploration Corp. ("HM Exploration” or "HM” or the "Company”) (CSE:HM) is pleased to announce that it has entered into a property option agreement dated March 11, 2026 (the "Agreement”) to acquire ...
Find latest business news from every corner of the globe at Reuters.com, your online source for breaking international news ...